Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
Status:
Completed
Trial end date:
1992-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of two surfactants, Exosurf Neonatal
(Burroughs Wellcome Co.) and Survanta (Ross Laboratories), for the treatment of neonatal
respiratory distress syndrome.